Mesoblast (MESO) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2025)
Mesoblast (MESO) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Mesoblast | 18.89 Bn | 18.76 Bn | - | 78.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 78.59% |
| Jun 30, 2025 | -99.71% |
| Dec 31, 2024 | -14.26% |
| Jun 30, 2024 | 42,839.57% |
| Dec 31, 2023 | -24.74% |
| Jun 30, 2023 | -33.64% |
| Mar 31, 2023 | -33.84% |
| Dec 31, 2022 | -37.00% |
| Sep 30, 2022 | -35.05% |
| Jun 30, 2022 | -32.31% |
| Mar 31, 2022 | -24.96% |
| Dec 31, 2021 | -23.69% |
| Sep 30, 2021 | 19.88% |
| Jun 30, 2021 | 31.75% |
| Mar 31, 2021 | 52.11% |
| Dec 31, 2020 | 108.30% |
| Sep 30, 2020 | 134.56% |
| Jun 30, 2020 | 177.60% |
| Mar 31, 2020 | 138.18% |
| Dec 31, 2019 | 78.42% |